Lisa DeFrancesco

Insider Reports History

Location
C/O Intercept Pharmaceuticals, Inc., 10 Hudson Yards, Floor 37, New York, NY
Signature
/s/ Lisa M. DeFrancesco
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Lisa DeFrancesco:

Stock Role Class Num Shares Value Price $ Report Date Ownership
INTERCEPT PHARMACEUTICALS, INC. SVP, IR & Corp. Affairs Common Stock 10.3K $196K $19.00 Dec 31, 2021 Direct
LEXICON PHARMACEUTICALS, INC. SVP, IR and Corp Comm Restricted Stock Units 49.3K $33.1K $0.67 Feb 28, 2025 Direct
LEXICON PHARMACEUTICALS, INC. SVP, IR and Corp Comm Common Stock 15.6K $10.4K $0.67 Feb 28, 2025 Direct
LEXICON PHARMACEUTICALS, INC. SVP, IR and Corp Comm Stock Option (Right to Buy) 577K Feb 13, 2025 Direct

Insider Reports Filed by Lisa DeFrancesco

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LXRX LEXICON PHARMACEUTICALS, INC. Feb 28, 2025 3 -$6.09K 4 Mar 3, 2025 SVP, IR and Corp Comm
LXRX LEXICON PHARMACEUTICALS, INC. Feb 13, 2025 2 $0 4 Feb 18, 2025 VP, IR and Corp Comm
LXRX LEXICON PHARMACEUTICALS, INC. Oct 2, 2024 0 $0 3 Oct 7, 2024 VP, IR and Corp Strategy
ICPT INTERCEPT PHARMACEUTICALS, INC. Dec 31, 2021 1 -$8.83K 4 Jan 4, 2022 SVP, IR & Corp. Affairs
ICPT INTERCEPT PHARMACEUTICALS, INC. Sep 30, 2021 1 -$3.03K 4 Oct 4, 2021 SVP, IR & Corp. Affairs
ICPT INTERCEPT PHARMACEUTICALS, INC. Sep 1, 2021 1 -$8.1K 4 Sep 3, 2021 SVP, IR & Corp. Affairs